MS-8209, a water-soluble amphotericin B derivative, affects both scrapie agent replication and PrPres accumulation in Syrian hamster scrapie.

References

1. Adjou K. T., Demaimay R., Lasmézas C., Deslys J. P., Seman M., Dormont D. 1995; MS-8209, a new amphotericin B derivative, provides enhanced efficacy in delaying hamster scrapie. Antimicrobial Agents and Chemotherapy 39:2810–2812
   [Google Scholar]
2. Adjou K. T., Demaimay R., Lasmézas C. I., Seman M., Deslys J. P., Dormont D. 1996; Differential effects of a new amphotericin B derivative, MS-8209, on mouse BSE and scrapie: implications for the mechanism of action of polyene antibiotics. Research in Virology 147:213–218
   [Google Scholar]
3. Adjou K. T., Deslys J.-P., Demaimay R., Dormont D. 1997; Probing the dynamics of prion diseases with amphotericin B. Trends in Microbiology 5:27–31
   [Google Scholar]
4. Adjou K. T., Deslys J. P., Demaimay R., Seman M., Dormont D. 1998; Prospects for the pharmacological treatment of human prion diseases. CNS Drugs 10:83–89
   [Google Scholar]
5. Amyx H., Salazar A. M., Gajdusek D. C., Gibbs C. J. 1984; Chemotherapeutic trials in experimental slow virus disease. Neurology 34: (Suppl.) 149
   [Google Scholar]
6. Bolton D. C., McKinley M. P., Prusiner S. B. 1982; Identification of a protein that purifies with the scrapie prion. Science 218:1309–1311
   [Google Scholar]
7. Brown P. 1990; A therapeutic panorama of the spongiform encephalopathies. Antiviral Chemistry & Chemotherapy 1:75–83
   [Google Scholar]
8. Caughey B., Chesebro B. 1997; Prion protein and the transmissible spongiform encephalopathies. Trends in Cell Biology 7:56–62
   [Google Scholar]
9. Demaimay R., Adjou K., Lasmézas C., Lazarini F., Cherifi K., Seman M., Deslys J.-P., Dormont D. 1994; Pharmacological studies of a new derivative of amphotericin B, MS-8209, in mouse and hamster scrapie. Journal of General Virology 75:2499–2503
   [Google Scholar]
10. Demaimay R., Adjou K. T., Beringue V., Demart S., Lasmézas C. I., Deslys J.-P., Seman M., Dormont D. 1997; Late treatment with polyene antibiotics can prolong the survival time of scrapie-infected animals. Journal of Virology 71:9685–9689
    [Google Scholar]
11. Diringer H., Ehlers B. 1991; Chemoprophylaxis of scrapie in mice. Journal of General Virology 72:457–460
    [Google Scholar]
12. Dormont D., Delpech B., Delpech A., Courcel M. N., Viret J., Markovits P., Court L. 1981; Hyperproduction de protéine gliofibrillaire acide (GFAP) au cours de l′ évolution de la tremblante expérimentale de la souris. Comptes Rendus de l’Académic des Sciences de Paris 293:53–56
    [Google Scholar]
13. Ehlers B., Diringer H. 1984; Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen. Journal of General Virology 65:1325–1330
    [Google Scholar]
14. Georgsson G., Gisladottir E., Arnadottir S. 1993; Quantitative assessment of the astrocytic response in natural scrapie of sheep. Journal of Comparative Pathology 108:229–240
    [Google Scholar]
15. Hill A. F., Desbruslais M., Joiner S., Sidle K. C. L., Gowland I., Collinge J., Doey L. J., Lantos P. 1997; The same prion strain causes vCJD and BSE. Nature 389:448–450
    [Google Scholar]
16. Ingrosso L., Ladogana A., Pocchiari M. 1995; Congo red prolongs the incubation period in scrapie–infected hamsters. Journal of Virology 69:506–508
    [Google Scholar]
17. Kimberlin R. H., Walker C. A. 1983; The antiviral compound HPA– 23 can prevent scrapie when administered at the time of infection. Archives of Virology 78:9–18
    [Google Scholar]
18. Kimberlin R. H., Walker C. A. 1986; Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions. Antimicrobial Agents and Chemotherapy 30:409–413
    [Google Scholar]
19. Ladogana A., Casaccia P., Ingrosso L., Cibati M., Salvatore M., Xi Y.-G., Masullo C., Pocchiari M. 1992; Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. Journal of General Virology 73:661–665
    [Google Scholar]
20. Lasmézas C. I., Deslys J. P., Robain O., Jaegly A., Beringue V., Peyrin J. M., Fournier J. G., Hauw J. J., Rossier J., Dormont D. 1997; Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275:402–405
    [Google Scholar]
21. Lazarini F., Boussin F., Deslys J. P., Tardy M., Dormont D. 1994; Astrocyte gene expression in experimental mouse scrapie. Journal of Comparative Pathology 111:87–98
    [Google Scholar]
22. Mackenzie A. 1983; Immunohistochemical demonstration of glial fibrillary acidic protein in scrapie. Journal of Comparative Pathology 93:251–259
    [Google Scholar]
23. McKenzie D., Kaczkowski J., Marsh R., Aiken J. 1994; Amphotericin B delays both scrapie agent replication and PrP-res accumulation early in infection. Journal of Virology 68:7534–7536
    [Google Scholar]
24. Manuelidis L., Fritch W., Xi Y. G. 1997; Evolution of a strain of CJD that induces BSE-like plaques. Science 277:94–98
    [Google Scholar]
25. Manuelidis L., Fritch W., Zaitsev I. 1998; Dapsone to delay symptoms in Creutzfeldt–Jakob disease. Lancet 352:456
    [Google Scholar]
26. Medoff G., Brajtburg J., Kobayashi G. S., Bolard J. 1983; Antifungal agents useful in therapy of systemic fungal infections. Annual Review of Pharmacology and Toxicology 23:303–330
    [Google Scholar]
27. Merz P. A., Somerville R. A., Wisniewski H. M., Manuelidis L., Manuelidis E. E. 1983; Scrapie–associated fibrils in Creutzfeldt–Jakob disease. Nature 306:474–476
    [Google Scholar]
28. Pocchiari M., Schmittinger S., Masullo C. 1987; Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters. Journal of General Virology 68:219–223
    [Google Scholar]
29. Pocchiari M., Casaccia P., Ladogana A. 1989a; Amphotericin B: a novel class of antiscrapie drugs. Journal of Infectious Diseases 160:795–802
    [Google Scholar]
30. Pocchiari M., Schmittinger S., Ladogana A., Masullo C. 1989b; Effects of amphotericin B in intracerebrally scrapie inoculated hamsters. In Unconventional Virus Diseases of the Central Nervous System pp 314–323 Edited by Dormont D., Court L. A., Brown P., Kingsbury D. T. Fontenay aux Roses: CEA Diffusion;
    [Google Scholar]
31. Pocchiari M., Ingrosso L., Cardone F., Ladogana A., Eleni C., Agrimi U. 1996; Effect of amphotericin B on 263K and 139H strains of scrapie in Armenian hamsters. In Transmissible Subacute Spongiform Encephalopathies: Prion Diseases pp 185–190 Edited by Court L., Dodet B. Paris: Elsevier;
    [Google Scholar]
32. Prusiner S. B. 1982; Novel proteinaceous infectious particles cause scrapie. Science 216:136–144
    [Google Scholar]
33. Prusiner S. B. 1992; Chemistry and biology of prions. Biochemistry 31:12277–12288
    [Google Scholar]
34. Reed L. J., Muench H. 1938; A simple method of estimating fifty percent endpoints. American Journal of Hygiene 27:493–496
    [Google Scholar]
35. Saint Julien L., Joly V., Seman M., Carbon C., Yeni P. 1992; Activity of MS–8209, a nonester amphotericin B derivative, in treatment of experimental systemic mycoses. Antimicrobial Agents and Chemotherapy 36:2722–2728
    [Google Scholar]
36. Somerville R. A., Dunn A. J. 1996; The association between PrP and infectivity in scrapie and BSE infected mouse brain. Archives of Virology 141:275–289
    [Google Scholar]
37. Tagliavini F., McArthur R. A., Canciani B., Giaccone G., Porro M., Bugiani M., Lievens P. M.-J., Bugiani O., Peri E., Dall’Ara P., Rocchi M., Poli G., Forloni G., Bandiera T., Varasi M., Suarato A., Cassutti P., Cervini M. A., Lansen J., Salmona M., Post C. 1997; Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science 276:1119–1122
    [Google Scholar]
38. Weissmann C. 1991; Spongiform encephalopathies. The prion′s progress. Nature 349:569–571
    [Google Scholar]
39. Xi Y. G., Ingrosso L., Ladogana A., Masullo C., Pocchiari M. 1992; Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature 356598–601
    [Google Scholar]